Moneycontrol PRO

FiDEX 2026

FiDEX 2026

SHOW NAMES

Trending Topics

business

Intas Pharma IPO likely, plans to raise Rs 1000-1200 cr

Intas Pharma is likely to file Draft Red Herring Prospectus (DRHP) with Securities and Exchange Board of India (Sebi), in the next two weeks. It has decided to revive its IPO plan.

first published: May 20, 2013 07:30 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347